Amphion Innovations plc Partner Company, DataTern,
Signs Three IP License Agreements worth $1.65m

London and New York, 5 May 2009 – Amphion Innovations plc (LSE: AMP) (“Amphion”), the developer of medical and technology businesses, today announces that DataTern, Inc., has signed non-exclusive intellectual property license agreements with three leading international corporations for a total of $1.65 million. DataTern has signed seven licenses since it commenced licensing of this product in June 2008, generating total revenues of approximately $7 million. DataTern has now licensed its intellectual property into the financial, credit card, retail, leisure, healthcare, and software industries.

Joseph Flicek, DataTern’s Chief Executive Officer, said, “We have made rapid progress in a relatively short period of time, demonstrating the value that can be extracted from our intellectual property portfolio. We believe there are a large number of potential licensees in a broad spectrum of industries for our IP. Currently, we are in active discussions with six other major corporations and we continue to add to this list.”

DataTern, Inc., wholly owned by Amphion Innovations plc, was established in order to commercialise selected intellectual property opportunities in partnership with Amphion’s Partner Companies.

Richard Morgan, Chief Executive Officer of Amphion, said, “Today’s announcement demonstrates the value that Amphion can generate for its shareholders through monetising our intellectual property. We continue to add further patents and software though the activities of DataTern and our Partner Companies and we look forward to signing further license agreements.”

For further information please contact

Amphion Innovations plc
Charlie Morgan, Director of Communications
+1 (212) 210 6224

Cardew Group
Tim Robertson/ Jamie Milton/ Matthew Law
+44 20 7930 0777

Charles Stanley (Nominated Adviser)
Mark Taylor/ Freddy Crossley
+44 20 7149 6000

About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has a significant shareholding in eight Partner Companies, developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web:


About DataTern, Inc.
DataTern owns and develops critical technology that provides next generation software solutions for its customers. DataTern’s patented product offerings include ObjectSpark® Technologies, which allow customers to develop their own customised data service layers, making the company’s offerings valuable to most industries, including automotive, banking, chemical, communications, financial, government, healthcare, insurance, pharmaceutical, trading, and many others. Non-exclusive licenses for DataTern’s technologies and patents are available on reasonable and non-discriminatory terms.

For licensing terms, please contact

On the web: